Sharief et al. (26) |
Retrospective study |
3,136 children/adolescents and 3,454 adults |
25(OH)D levels <15 ng/ml associated with peanut allergy, no consistent associations seen in adults |
25(OH)D deficiency <15 ng/ml, insufficiency 15–29 ng/ml |
Mullins et al. (27) |
Retrospective study |
115 peanut allergic patients younger than 72 months |
Non-linear relationship between neonatal 25(OH)D3 levels and peanut allergy in children under 6 months of age, slightly higher levels (75–99.9 nmol/L) linked with lower vs. those in the reference group (50–74.9 nmol/L) |
Neonatal concentration of 25(OH)D divided into four groups: <50, 50–74.9, 75–99.9, and >100 nmol/L. The reference group was considered between 50 and 74.9 nmol/L |
Kim et al. (28) |
Retrospective study |
18,181 patients 10 years or older (2,814 patients with food-induced anaphylaxis and 15,367 people with available serum vitamin D measurements) |
Higher incidence of food-induced anaphylaxis in regions with lower vitamin D levels in the population |
Not defined |
Kull et al. (29) |
Prospective birth cohort |
4,089 newborn infants were followed for 4 years |
Water-soluble form increased the risk of allergic disease in children up to the age of 4 years compared with supplementation of same vitamin given in peanut oil |
Not defined |
Camargo et al. (30) |
Prospective pre-birth cohort study |
1,194 mother–child pairs followed up through age 3 years |
Higher maternal intake of vitamin D during pregnancy may decrease the risk of recurrent wheeze in early childhood |
Not defined |
Nwaru et al. (31) |
Prospective cohort study |
971 children with 5-year follow-up |
It was found that maternal intake of vitamin D was inversely associated with sensitization to food allergens |
Not defined |
Liu et al. (32) |
Prospective birth cohort study |
649 children who were enrolled at birth and followed from birth onward |
Vitamin D deficiency may increase the risk of food sensitization among individuals with certain genotypes |
Cord blood 25(OH)D3 <11 ng/ml |
Jones et al. (33) |
Prospective birth cohort study |
231 mother–child pairs, derived from a larger (n = 669) prospective birth cohort, followed up until 1 year of age |
Reduced fetal exposure to vitamin D increases the risk of eczema in infants by 12 months of age |
25(OH)D3 levels cutoffs were divided in <50 nmol/L, 50–74.99 nmol/L, >75 nmol/L |
Weisse et al. (34) |
Prospective |
378 mother–child pairs followed up until 2 years of age |
High vitamin D levels in pregnancy and at birth may contribute to a higher risk for food allergy |
The assay detection limit was defined as 6.7 ng/ml for maternal 25(OH)D3 and 5.2 ng/ml for maternal 25(OH)D2. Detection limit for cord blood 25(OH)D3 and D2 was 3 ng/ml |
Allen et al. (35) |
Australian large prospective cohort study |
577 infants, 1 year of age |
Vitamin D insufficiency more likely associated with peanut and/or egg allergy. Vitamin D insufficiency linked to multiple food allergies (≥2) rather than a single food allergy |
Vitamin D insufficiency: ≤ 50 nmol/L |
Chiu et al. (36) |
Prospective study |
186 children (0–4 years) |
Cord blood 25(OH)D levels inversely linked with the risk of milk sensitization at 2 years of age |
Low vitamin D levels <20 ng/ml |
Chawes et al. (37) |
Prospective clinical study |
257 children |
Cord blood 25(OH) vitamin D levels defined as <50 nmol/L was not associated with allergic sensitization |
Cord blood 25(OH)-Vitamin D: deficient, 50 nmol/L; insufficient, 50–75 nmol/L; sufficient, >75 nmol/L |
Hennessy et al. (38) |
Prospective Cork BASELINE Birth Cohort Study |
Vitamin D was measured in maternal sera at 15 weeks of gestation (n = 1,537) and umbilical cord blood (n = 1,050) |
The investigators did not observe any association between vitamin D during pregnancy or at birth with allergic disease outcomes at 2 and 5 years old |
Maternal 25 (OH) D divided into <30 nmol/L; 30–49.9 nmol/L; 50–74.9 nmol/L; ≥75 nmol/L |
Ercan et al. (39) |
Prospective, observational, case–control study |
111 children <2 years of age |
No statistically significant relationship between the CMPA group and healthy controls in terms of 25(OH)D levels |
Vitamin D deficiency ≤ 20 ng/ml, insufficiency 21–29 ng/ml, adequate ≥30 ng/ml |
Sardecka et al. (48) |
Prospective two-stage study |
138 infants with CMA and 101 healthy infants |
Children with increased Foxp3mRNA expression (predictive of faster gain of tolerance in infants with CMA) have lower serum vitamin D levels than healthy children |
25 (OH)D concentration sufficient ≥30 ng/ml for the Polish population |
Baek et al. (49) |
Cross-sectional study |
226 children aged 3–24 months with atopic dermatitis or suspected food allergy |
VDD increased the risk of food allergen sensitization especially to milk and wheat. The polysensitization group had significantly lower levels of 25(OH)D than the non-sensitization and monosensitization group |
Serum 25(OH)D levels: deficiency, <20.0 ng/ml; insufficiency, 20.0–29.0 ng/ml; and sufficiency, ≥30.0 ng/ml |
Rosendahl et al. (50) |
Randomized controlled study |
975 infants followed up until 12 months of age |
No differences between the vitamin D supplementation groups in food sensitization at 12 months. Possible adverse effect of high concentrations of vitamin D |
25 (OH)D2 considered sufficient for concentrations ≥50 nmol/L |
Guo et al. (51) |
Large observational study |
2,642 children followed up until 2 years of age |
No evidence found supporting the link between low levels of 25 (OH)D and allergic sensitization to various allergens |
25(OH)D concentrations insufficient <75 nmol/L and sufficient otherwise |
Thorisdottir et al. (52) |
Longitudinal Icelandic study |
144 children followed up until 6 years of age |
At 12 months, IgE-sensitized children had a lower intake of vitamin D, but no significant difference in mean serum 25(OH)D was found between IgE-sensitized and non-sensitized children, nor at 12 months or 6 years |
Vitamin D deficient: <30 nmol/L and vitamin D intake from diet and supplements combined did not exceed 25 μg/day in infancy or at 6 years |